Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage – NV-387 Could Become a Revolutionary Antiviral for Respiratory Viral Infections SHELTON, CONNECTICUT / ACCESS Newswire / September 30, ...
Future Virology. 2012;7(9):871-883. †Only reference [97]. CSF: Cerebrospinal fluid; HHV: Human herpes virus; JCV: Polyomavirus JC; MeV: Measles virus; MS: Multiple sclerosis. The authors have no ...
From this brief review regarding the possible relationship between infectious agents and MS, it appears clear that this phenomenon cannot be viewed in the simplistic way of the dogma 'a specific virus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback